Stephen V Liu, Director of Thoracic Oncology, Chief of the Division of Hematology and Oncology, and Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared a post on X:
“How should we manage HER2 mutant NSCLC – antibody drug conjugate or TKI?
Drs. Balazs Halmos and Joshua Reuss will debate their case at DCLung25 – next Saturday, October 4th!
Registration free for students and trainees!
Register today.”
More from Stephen V Liu on Oncodaily.